Zaccardelli David

Zaccardelli David is listed in filings as Director at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including 1 public disclosure. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jan 7, 2026. Reported amounts are shown as $897.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.